-
公开(公告)号:NO753806A
公开(公告)日:1976-06-09
申请号:NO753806
申请日:1975-11-13
Applicant: HOECHST AG
IPC: A61K31/52 , C07D473/06 , C07D
CPC classification number: C07D473/06
-
公开(公告)号:SE7513759A
公开(公告)日:1976-06-08
申请号:SE7513759
申请日:1975-12-05
Applicant: HOECHST AG
IPC: A61K31/52 , C07D473/06 , C07D473/04
CPC classification number: C07D473/06
-
公开(公告)号:DK145676B
公开(公告)日:1983-01-24
申请号:DK321574
申请日:1974-06-14
Applicant: HOECHST AG
IPC: A61K31/52 , A61K31/522 , A61P7/02 , A61P9/08 , C07D473/06 , C07D473/04
Abstract: Compounds of general formula (I) wherein one of the groups R1 and R3 is a straight-chain or branched oxoalkyl group consisting from 5 to 8 carbon atoms and the oxygen atom is attached to a non-terminal carbon atom and is separated from the nearest ring nitrogen atom by at least 3 carbon atoms in ( omega -1)-oxoalkyl groups and by at least 4 carbon atoms in oxoalkyl groups in which the oxygen atom is separated from the terminal carbon atom by more than one carbon atom, R2 and the other one of groups R1 and R3 are straight chain or branched alkyl groups containing from 1 to 12 carbon atoms but wherein that group R1 or R3 which is other than an oxoalkyl group may also be hydrogen, one nitrogen-bound substituent being hydrogen or alkyl containing more than 1 carbon atom, and physiologically acceptable acid addition salts thereof, a process for their preparation and pharmaceutical compositions containing said compounds.
-
公开(公告)号:SE423631B
公开(公告)日:1982-05-17
申请号:SE7407913
申请日:1974-06-14
Applicant: HOECHST AG
IPC: A61K31/52 , A61K31/522 , A61P7/02 , A61P9/08 , C07D473/06
Abstract: Compounds of general formula (I) wherein one of the groups R1 and R3 is a straight-chain or branched oxoalkyl group consisting from 5 to 8 carbon atoms and the oxygen atom is attached to a non-terminal carbon atom and is separated from the nearest ring nitrogen atom by at least 3 carbon atoms in ( omega -1)-oxoalkyl groups and by at least 4 carbon atoms in oxoalkyl groups in which the oxygen atom is separated from the terminal carbon atom by more than one carbon atom, R2 and the other one of groups R1 and R3 are straight chain or branched alkyl groups containing from 1 to 12 carbon atoms but wherein that group R1 or R3 which is other than an oxoalkyl group may also be hydrogen, one nitrogen-bound substituent being hydrogen or alkyl containing more than 1 carbon atom, and physiologically acceptable acid addition salts thereof, a process for their preparation and pharmaceutical compositions containing said compounds.
-
公开(公告)号:DK321574A
公开(公告)日:1975-02-10
申请号:DK321574
申请日:1974-06-14
Applicant: HOECHST AG
IPC: A61K31/52 , A61K31/522 , A61P7/02 , A61P9/08 , C07D473/06 , C07D
Abstract: Compounds of general formula (I) wherein one of the groups R1 and R3 is a straight-chain or branched oxoalkyl group consisting from 5 to 8 carbon atoms and the oxygen atom is attached to a non-terminal carbon atom and is separated from the nearest ring nitrogen atom by at least 3 carbon atoms in ( omega -1)-oxoalkyl groups and by at least 4 carbon atoms in oxoalkyl groups in which the oxygen atom is separated from the terminal carbon atom by more than one carbon atom, R2 and the other one of groups R1 and R3 are straight chain or branched alkyl groups containing from 1 to 12 carbon atoms but wherein that group R1 or R3 which is other than an oxoalkyl group may also be hydrogen, one nitrogen-bound substituent being hydrogen or alkyl containing more than 1 carbon atom, and physiologically acceptable acid addition salts thereof, a process for their preparation and pharmaceutical compositions containing said compounds.
-
公开(公告)号:FI206574A
公开(公告)日:1975-01-12
申请号:FI206574
申请日:1974-07-05
Applicant: HOECHST AG
IPC: C07D473/06 , C07D473/08 , C07D473/10 , C07D
-
公开(公告)号:ZA743760B
公开(公告)日:1975-06-25
申请号:ZA743760
申请日:1974-06-12
Applicant: HOECHST AG
IPC: A61K31/52 , A61K31/522 , A61P7/02 , A61P9/08 , C07D473/06 , C07D57/40
Abstract: Compounds of general formula (I) wherein one of the groups R1 and R3 is a straight-chain or branched oxoalkyl group consisting from 5 to 8 carbon atoms and the oxygen atom is attached to a non-terminal carbon atom and is separated from the nearest ring nitrogen atom by at least 3 carbon atoms in ( omega -1)-oxoalkyl groups and by at least 4 carbon atoms in oxoalkyl groups in which the oxygen atom is separated from the terminal carbon atom by more than one carbon atom, R2 and the other one of groups R1 and R3 are straight chain or branched alkyl groups containing from 1 to 12 carbon atoms but wherein that group R1 or R3 which is other than an oxoalkyl group may also be hydrogen, one nitrogen-bound substituent being hydrogen or alkyl containing more than 1 carbon atom, and physiologically acceptable acid addition salts thereof, a process for their preparation and pharmaceutical compositions containing said compounds.
-
公开(公告)号:NO742464L
公开(公告)日:1975-02-10
申请号:NO742464
申请日:1974-07-05
Applicant: HOECHST AG
IPC: C07D473/06 , C07D473/08 , C07D473/10 , C07D
-
公开(公告)号:SE7310986L
公开(公告)日:1975-01-13
申请号:SE7310986
申请日:1973-08-10
Applicant: HOECHST AG
IPC: C07D473/06 , C07D473/08 , C07D473/10 , C07D57/40 , C07D473/04
-
公开(公告)号:NO742121L
公开(公告)日:1975-01-13
申请号:NO742121
申请日:1974-06-11
Applicant: HOECHST AG
IPC: A61K31/52 , A61K31/522 , A61P7/02 , A61P9/08 , C07D473/06 , C07D
Abstract: Compounds of general formula (I) wherein one of the groups R1 and R3 is a straight-chain or branched oxoalkyl group consisting from 5 to 8 carbon atoms and the oxygen atom is attached to a non-terminal carbon atom and is separated from the nearest ring nitrogen atom by at least 3 carbon atoms in ( omega -1)-oxoalkyl groups and by at least 4 carbon atoms in oxoalkyl groups in which the oxygen atom is separated from the terminal carbon atom by more than one carbon atom, R2 and the other one of groups R1 and R3 are straight chain or branched alkyl groups containing from 1 to 12 carbon atoms but wherein that group R1 or R3 which is other than an oxoalkyl group may also be hydrogen, one nitrogen-bound substituent being hydrogen or alkyl containing more than 1 carbon atom, and physiologically acceptable acid addition salts thereof, a process for their preparation and pharmaceutical compositions containing said compounds.
-
-
-
-
-
-
-
-
-